FAM129B is a novel regulator of Wnt/β-catenin signal transduction in melanoma cells

F1000Research

Volumn 2, Issue 1, 2013, Pages

  Conrad, Willliam ^a,b   Major, Michael B ^a,c   Cleary, Michele A ^d,e   Ferrer, Marc ^e,f   Roberts, Brian ^d,g   Marine, Shane ^e   Chung, Namjin ^d,h   Arthur, William T ^d,i   Moon, Randall T ^a,b,j   Berndt, Jason D ^a,b,j   Chien, Andy J ^j  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d ROSETTA INPHARMATICS   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY   (United States)

^h BRISTOL MYERS SQUIBB   (United States)

ⁱ SEATTLE GENETICS INC   (United States)

^j UNIVERSITY OF WASHINGTON   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CATENIN; FAM129B PROTEIN; REGULATOR PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; WNT3A PROTEIN;

APOPTOSIS; ARTICLE; AXIN2 GENE; CONTROLLED STUDY; FIBROSARCOMA CELL LINE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; MELANOMA CELL; PROTEOMICS; WNT SIGNALING PATHWAY;

EID: 84901772402     PISSN: 20461402     EISSN: None     Source Type: Journal    
DOI: 10.12688/f1000research.2-134.v2     Document Type: Article

References (24)

1. Kageshita T Hamby CV Ishihara T: Loss of beta-catenin expression associated with disease progression in malignant melanoma. Br J Dermatol. 2001;145(2):210-6. 11531781 10.1046/j.1365-2133.2001.04336.x
2. Kohler BA Ward E McCarthy BJ: Annual Report to the Nation on the Status of Cancer, 1975-2007, Featuring Tumors of the Brain and Other Nervous System. J Natl Cancer Inst. 2011;103(9):714-36. 21454908 10.1093/jnci/djr077 3086878
3. American Cancer Society. Cancer Facts & Figures 2011 [Internet]. American Cancer Society;2011. Reference Source
4. Chapman PB Hauschild A Robert C: Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011;364(26):2507-16. 21639808 10.1056/NEJMoa1103782 3549296
5. Flaherty KT Puzanov I Kim KB: Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med. 2010;363(9):809-19. 20818844 10.1056/NEJMoa1002011 3724529
6. Sosman JA Kim KB Schuchter L: Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. N Engl J Med. 2012;366(8):707-14. 22356324 10.1056/NEJMoa1112302 3724515
7. Maelandsmo GM Holm R Nesland JM: Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma. Clin Cancer Res. 2003;9(9):3383-8. 12960126
8. Bachmann IM Straume O Puntervoll HE: Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma. Clin Cancer Res. 2005;11(24 Pt 1):8606-14. 16361544 10.1158/1078-0432.CCR-05-0011
9. Chien AJ Moore EC Lonsdorf AS: Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model. Proc Natl Acad Sci U S A. 2009;106(4):1193-8. 19144919 10.1073/pnas.0811902106 2626610
10. Biechele TL Camp ND Fass DM: Chemical-genetic screen identifies riluzole as an enhancer of Wnt/β-catenin signaling in melanoma. Chem Biol. 2010;17(11):1177-82. 21095567 10.1016/j.chembiol.2010.08.012 3044442
11. Biechele TL Kulikauskas RM Toroni RA: Wnt/β-catenin signaling and AXIN1 regulate apoptosis triggered by inhibition of the mutant kinase BRAFV600E in human melanoma. Sci Signal. 2012;5(206):ra3. 22234612 10.1126/scisignal.2002274 3297477
12. Conrad WH Swift RD Biechele TL: Regulating the response to targeted MEK inhibition in melanoma: Enhancing apoptosis in NRAS- and BRAF-mutant melanoma cells with Wnt/β-catenin activation. Cell Cycle. 2012;11(20):3724-30. 22895053 10.4161/cc.21645 3495814
13. Old WM Shabb JB Houel S: Functional proteomics identifies targets of phosphorylation by B-Raf signaling in melanoma. Mol Cell. 2009;34(1):115-31. 19362540 10.1016/j.molcel.2009.03.007 2735263
14. Chen S Evans HG Evans DR: FAM129B/MINERVA, a novel adherens junction-associated protein, suppresses apoptosis in HeLa cells. J Biol Chem. 2011;286(12):10201-9. 21148485 10.1074/jbc.M110.175273 3060473
15. Biechele TL Moon RT: Assaying beta-catenin/TCF transcription with beta-catenin/TCF transcription-based reporter constructs. Methods Mol Biol. 2008;468:99-110. 19099249 10.1007/978-1-59745-249-6_8
16. Hoek KS Schlegel NC Brafford P: Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res. 2006;19(4):290-302. 16827748 10.1111/j.1600-0749.2006.00322.x
17. Sowa ME Bennett EJ Gygi SP: Defining the human deubiquitinating enzyme interaction landscape. Cell. 2009;138(2):389-403. 19615732 10.1016/j.cell.2009.04.042 2716422
18. Damsky WE Curley DP Santhanakrishnan M: β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas. Cancer Cell. 2011;20(6):741-54. 22172720 10.1016/j.ccr.2011.10.030 3241928
19. Fass D Haggarty S Scolnick E: Compositions of modulators of the wnt/beta-catenin pathway and benzamide and/or hydroxamic acid derivatives to treat bipolar disorde.2013. Reference Source
20. Willert K Brown JD Danenberg E: Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature. 2003;423(6938):448-52. 12717451 10.1038/nature01611
21. Bartz SR Zhang Z Burchard J: Small interfering RNA screens reveal enhanced cisplatin cytotoxicity in tumor cells having both BRCA network and TP53 disruptions. Mol Cell Biol. 2006;26(24):9377-86. 17000754 10.1128/MCB.01229-06 1698535
22. Major MB Roberts BS Berndt JD: New regulators of Wnt/beta-catenin signaling revealed by integrative molecular screening. Sci Signal. 2008;1(45):ra12. 19001663 10.1126/scisignal.2000037
23. Angers S Thorpe CJ Biechele TL: The KLHL12-Cullin-3 ubiquitin ligase negatively regulates the Wnt-beta-catenin pathway by targeting Dishevelled for degradation. Nat Cell Biol. 2006;8(4):348-57. 16547521 10.1038/ncb1381
24. Major MB Camp ND Berndt JD: Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling. Science. 2007;316(5827):1043-6. 17510365 10.1126/science/1141515